Photodynamic therapy for choriocapillaris using tin ethyl etiopurpurin (SnET2)

Ophthalmic Surgery and Lasers

Volumn 28, Issue 5, 1997, Pages 409-417

  Peyman, Gholam A ^a   Moshfeghi, Darius M ^a   Moshfeghi, Andrew ^a   Khoobehi, Bahram ^a   Doiron, Daniel R ^b   Primbs, George B ^c   Crean, David H ^b  

^a LSU EYE CENTER   (United States)

^b PDT Inc   (United States)

^c JULES STEIN EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETIOPURPURIN; LIPID EMULSION; PHOTOSENSITIZING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOROID CAPILLARY LAYER; CONTROLLED STUDY; DRUG EFFECT; ELECTRON MICROSCOPY; FLUORESCENCE ANGIOGRAPHY; MICROSCOPY; NONHUMAN; OPHTHALMOSCOPY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RABBIT; SUBRETINAL NEOVASCULARIZATION;

ANIMALS; CHOROID; ENDOTHELIUM, VASCULAR; FLUORESCEIN ANGIOGRAPHY; FUNDUS OCULI; INJECTIONS, INTRAVENOUS; NEOVASCULARIZATION, PATHOLOGIC; PHOTOCHEMOTHERAPY; PORPHYRINS; RABBITS; RADIATION-SENSITIZING AGENTS; RETINAL VESSELS;

EID: 0030911348     PISSN: 10823069     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Bressler NM, Bressler SB, Gragoudas ES. Clinical characteristics of choroidal neovascular membranes. Arch Ophthalmol. 1987;105:209-213.
2. Bressler NM, Bressler SB, Fine SL. Age-related macular degeneration. Surv Ophthalmol. 1988;32:375-413.
3. Gass DM. Pathogenesis of disciform detachment of the neuroepithelium: III. Senile disciform macular degeneration. Am J Ophthalmol. 1967;63:617-644.
4. Chandra SR, Gragoudas ES, Friedman E, Van Buskirk EM, Klein ML. Natural history of disciform degeneration of the macula. Am J Ophthalmol. 1974;78: 579-582.
5. Macular Photocoagulation Study Group. Argon laser photocoagulation for neovascular maculopathy: five-year results from randomized clinical trials. Arch Ophthalmol. 1991;109:1109-1114.
6. Macular Photocoagulation Study Group. Laser photocoagulation of juxtafoveal choroidal neovascularization: five-year results from randomized clinical trials. Arch Ophthalmol. 1994;112:500-509.
7. Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal neovascular lesions of age-related macular degeneration: updates findings from two clinical trials. Arch Ophthalmol. 1993;111: 1200-1209.
8. Kliman GH, Puliafito CA, Grossman GA, Gregory WA. Retinal and choroidal vessel closure using phthalocyanine photodynamic therapy. Lasers Surg Med. 1994;15:11-18.
9. Schmidt-Erfurth U, Hasan T, Gragoudas E, Michaud N, Flotte TJ, Birngruber R. Vascular targeting in photodynamic occlusion of subretinal vessels. Ophthalmology. 1994;101:1953-1961.
10. Miller JW, Walsh AW, Kramer M, et al. Photodynamic therapy of experimental choroidal neovascularization using lipoprotein-delivered benzoporphyrin. Arch Ophthalmol. 1995;113:810-818.
11. Moshfeghi DM, Peyman GA, Khoobehi B, Crean DH. Photodynamic occlusion of retinal vessels using tin ethyl etiopurpurin (SnET2): an efficacy study. Invest Ophthalmol Vis Sci. 1995;36(suppl):115. ARVO abstract.
12. Morgan AR, Razum NJ, Snyder AS, Doiron DR. Pre-clinical and clinical studies with tin ethyl etiopurpurin. Lasers Surg Med. 1995;7:59. Abstract.
13. Razum NJ, Snyder AB, Doiron DR. SnET2: clinical update. In: SPIE Proceedings. Optical Methods for Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy V. 1996;2675:43-46.
14. Morgan AR, Garbo GM, Keck RW, Selman SH. New photosensitizers for photodynamic therapy: combined effect of metallopurpurin derivatives and light on transplantable bladder tumors. Cancer Res. 1988; 48:194-198.
15. Henderson BW, Dougherty TJ. How does photodynamic therapy work? Photochem Photobiol. 1992;55: 145-157.
16. Reed MWR, Miller FN, Wieman TJ, Tseng MT, Pietsch CG. The effect of photodynamic therapy on the microcirculation. J Surg Res. 1988;45:452-459.
17. Ben-Hur E, Orenstein A. The endothelium and red blood cells as potential targets in PDT-induced vascular stasis. Int J Radiat Biol. 1991;60:293-301.
18. Gomer CJ, Doiron DR, White L, Jester JV, Dunn S, Szirth BC. Hematoporphyrin derivative photoradiation induced damage to normal and tumor tissue of the pigmented rabbit eye. Curr Eye Res. 1984;3:229-237.
19. Murphree AL, Cote M, Gomer CJ. The evolution of photodynamic therapy in the treatment of intraocular tumors. Photochem Photobiol. 1987;46:919-923.
20. Hennessey MJ, Epstein RJ. Photodynamic therapy for corneal neovascularization: clinical trials. Invest Ophthalmol Vis Sci. 1994;35:1350. ARVO abstract.
21. Kliman GH, Puliafito CA, Stern D, Borirakchanyavat S, Gregory WA. Phthalocyanine photodynamic therapy: new strategy for closure of choroidal neovascularization. Lasers Surg Med. 1994;15:2-10.
22. Lin SC, Lin CP, Feld JR, Duker JS, Puliafito CA. The photodynamic occlusion of choroidal vessels using benzoporphyrin derivative. Curr Eye Res. 1994;13: 513-522.
23. Tsilimbaris MK, Pallikaris IG, Naoumidi II, Vlahonikolis IG, Tsakalof AK, Lydataki SE. Phthalocyanine mediated photodynamic thrombosis of experimental corneal neovascularization: effect of phthalocyanine dose and irradiation onset time on vascular occlusion rate. Lasers Surg Med. 1994;15:19-31.
24. Ben-Hur E, Orenstein A. The endothelium and red blood cells as potential targets in PDT-induced vascular stasis. Int J Radiat Biol. 1991;60:293-301.
25. Hill RA, Crean DH, Doiron DR, Liaw LH, Hamilton A, Berns MW. Photodynamic therapy (PDT) for antifibrosis in a rabbit model of filtration surgery. Invest Ophthalmol Vis Sci. 1995;36(suppl):877. ARVO abstract.